Cargando…
Somatic comorbidity and the progression of cognitive impairment
BACKGROUND: There are usually multiple factors underlying dementia in old age. Somatic comorbidity is one important element that influences the progression of cognitive impairment. OBJECTIVE: The goal of this study was to assess the relationship between the progression of cognitive impairment and th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691469/ https://www.ncbi.nlm.nih.gov/pubmed/38046465 http://dx.doi.org/10.3389/fnagi.2023.1219449 |
_version_ | 1785152744462483456 |
---|---|
author | Bidzan, Leszek Jurek, Paweł Olech, Michał Bidzan-Wiącek, Monika Bidzan-Bluma, Ilona Bidzan, Mariola |
author_facet | Bidzan, Leszek Jurek, Paweł Olech, Michał Bidzan-Wiącek, Monika Bidzan-Bluma, Ilona Bidzan, Mariola |
author_sort | Bidzan, Leszek |
collection | PubMed |
description | BACKGROUND: There are usually multiple factors underlying dementia in old age. Somatic comorbidity is one important element that influences the progression of cognitive impairment. OBJECTIVE: The goal of this study was to assess the relationship between the progression of cognitive impairment and the presence and severity of comorbidities based on a four-year observation. MATERIAL: Out of 128 patients from the Clinic for Outpatients in Gdansk, who were recruited into the study based on the criteria of the Working Group on Mild Cognitive Impairment, a total of 93 participants completed the four-year observation. Only the data from participants who completed the full period of observations were analysed. The mean age of the group was M = 75.93 (SD = 9.43). The level of progression of cognitive impairment was measured using the Clinical Dementia Rating Scale – Sum of Boxes, the severity of comorbidities was measured using the modified Cumulative Illness Rating Scale, and, additionally, at the time of inclusion in the study, participants were assessed using the MMSE scale and the Activity Scale, and sociodemographic data were collected. The Generalized Estimating Equations method was employed to fit a marginal model for analyzing the data collected in a repeated measures design. The tested model elucidated the role of the overall severity of comorbidities in explaining the progression of cognitive impairment, while controlling for everyday activity and basic demographic variables. RESULTS: During the four-year observation, a significant decline in cognitive function (B = 1.86, p < 0.01) was observed in the examined sample. The statistical analysis revealed that individuals with higher overall severity of comorbidities exhibited significantly more pronounced progression of cognitive impairment over time. Regarding particular comorbidities, metabolic diseases were found to be associated with a poorer prognosis (rho = 0.41, p < 0.05). Furthermore, a time physical activity interaction was identified as predicting cognitive impairment, indicating that individuals who were more physically active at the beginning of the study exhibited significantly less pronounced progression of cognitive impairment over the course of the 4 years. CONCLUSION: This study suggests the important roles of comorbidities and physical activity for the prognosis of mild cognitive impairment. |
format | Online Article Text |
id | pubmed-10691469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106914692023-12-02 Somatic comorbidity and the progression of cognitive impairment Bidzan, Leszek Jurek, Paweł Olech, Michał Bidzan-Wiącek, Monika Bidzan-Bluma, Ilona Bidzan, Mariola Front Aging Neurosci Aging Neuroscience BACKGROUND: There are usually multiple factors underlying dementia in old age. Somatic comorbidity is one important element that influences the progression of cognitive impairment. OBJECTIVE: The goal of this study was to assess the relationship between the progression of cognitive impairment and the presence and severity of comorbidities based on a four-year observation. MATERIAL: Out of 128 patients from the Clinic for Outpatients in Gdansk, who were recruited into the study based on the criteria of the Working Group on Mild Cognitive Impairment, a total of 93 participants completed the four-year observation. Only the data from participants who completed the full period of observations were analysed. The mean age of the group was M = 75.93 (SD = 9.43). The level of progression of cognitive impairment was measured using the Clinical Dementia Rating Scale – Sum of Boxes, the severity of comorbidities was measured using the modified Cumulative Illness Rating Scale, and, additionally, at the time of inclusion in the study, participants were assessed using the MMSE scale and the Activity Scale, and sociodemographic data were collected. The Generalized Estimating Equations method was employed to fit a marginal model for analyzing the data collected in a repeated measures design. The tested model elucidated the role of the overall severity of comorbidities in explaining the progression of cognitive impairment, while controlling for everyday activity and basic demographic variables. RESULTS: During the four-year observation, a significant decline in cognitive function (B = 1.86, p < 0.01) was observed in the examined sample. The statistical analysis revealed that individuals with higher overall severity of comorbidities exhibited significantly more pronounced progression of cognitive impairment over time. Regarding particular comorbidities, metabolic diseases were found to be associated with a poorer prognosis (rho = 0.41, p < 0.05). Furthermore, a time physical activity interaction was identified as predicting cognitive impairment, indicating that individuals who were more physically active at the beginning of the study exhibited significantly less pronounced progression of cognitive impairment over the course of the 4 years. CONCLUSION: This study suggests the important roles of comorbidities and physical activity for the prognosis of mild cognitive impairment. Frontiers Media S.A. 2023-11-17 /pmc/articles/PMC10691469/ /pubmed/38046465 http://dx.doi.org/10.3389/fnagi.2023.1219449 Text en Copyright © 2023 Bidzan, Jurek, Olech, Bidzan-Wiącek, Bidzan-Bluma and Bidzan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Aging Neuroscience Bidzan, Leszek Jurek, Paweł Olech, Michał Bidzan-Wiącek, Monika Bidzan-Bluma, Ilona Bidzan, Mariola Somatic comorbidity and the progression of cognitive impairment |
title | Somatic comorbidity and the progression of cognitive impairment |
title_full | Somatic comorbidity and the progression of cognitive impairment |
title_fullStr | Somatic comorbidity and the progression of cognitive impairment |
title_full_unstemmed | Somatic comorbidity and the progression of cognitive impairment |
title_short | Somatic comorbidity and the progression of cognitive impairment |
title_sort | somatic comorbidity and the progression of cognitive impairment |
topic | Aging Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691469/ https://www.ncbi.nlm.nih.gov/pubmed/38046465 http://dx.doi.org/10.3389/fnagi.2023.1219449 |
work_keys_str_mv | AT bidzanleszek somaticcomorbidityandtheprogressionofcognitiveimpairment AT jurekpaweł somaticcomorbidityandtheprogressionofcognitiveimpairment AT olechmichał somaticcomorbidityandtheprogressionofcognitiveimpairment AT bidzanwiacekmonika somaticcomorbidityandtheprogressionofcognitiveimpairment AT bidzanblumailona somaticcomorbidityandtheprogressionofcognitiveimpairment AT bidzanmariola somaticcomorbidityandtheprogressionofcognitiveimpairment |